Skip to main content
. 2021 Apr 9;20:177. doi: 10.1186/s12936-021-03709-y

Table 2.

Prevalence and density of P. vivax at baseline and endpoint

Baseline Endpoint p value OR/GMR (95%CI)
Parasite prevalence
 By microscopy 43/811 (5%)a 35/740 (5%)b 0.643 0.89 (0.54–1.44)
 By PCR 183/811 (23%) 135/740 (18%) 0.038* 0.77 (0.59–0.99)*
 By either test 192/811 (24%) 142/740 (19%) 0.035* 0.77 (0.59–0.98)*
 Median parasitaemia/µL (IQR) (microscopy) 112 (48–1000) 80 (16–1080) 0.832
 Median 18S copies/µL (IQR) (qPCR) (n baseline = 115, endpoint = 74) 192.2 (60.6–605.2) 177.7 (72.7–1535.0) 0.719
Gametocyte prevalence
 By microscopy 9/811 (1.1%) 14/740 (1.9%) 0.215 1.72 (0.69–4.53)
 By pvs25 49/744 (7%) 39/704 (5%) 0.442 0.83 (0.52–1.31)
 By either test 49/744 (7%) 39/704 (5%) 0.442 0.83 (0.52–1.31)
Gametocyte density (per μL)
 By microscopy (median) (IQR) 160 (28–200) 64 (32–170) 0.516
 By pvs25 (geometric mean) (95%CI) 56.4 (23.8–134.0) 65.6 (26.5–162.2) 0.810 0.9 (0.2–3.0)

OR odds ratio, GMR geometric mean ratio

aNine and bseven subjects were not confirmed by PCR during baseline and endpoint, respectively. This is presumably due to degraded DNA and possible LM false positive as 11 of 16 (69%) showed negative microscopy during cross check.

*p < 0.05